Full-Time

Medical Specialist I

Dermatology

Posted on 1/15/2025

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals

10,001+ employees

Develops medicines for serious diseases

Biotechnology
Healthcare

Compensation Overview

$141.4k - $184.8kAnnually

Senior

Houston, TX, USA

Must be based in or located in close proximity to the assigned territory; relocation will not be provided.

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Required Skills
Sales
Requirements
  • BA/BS in science or business (master’s degree a plus)
  • Minimum of 5 years’ specialty sales experience in the Pharmaceutical or Biotechnology industry
  • Previous dermatology experience is required
  • Must be based in or located in close proximity to the assigned territory (relocation will not be provided)
  • Ability to travel (30-50%)
Responsibilities
  • Engaging Dermatologists and other key customers within an assigned geographical universe
  • Presenting clinically focused selling messages to create and grow revenue
  • Consistently delivering product goals
  • Demonstrating strong and consistent sales performance that exceeds forecast and expectations
  • Accomplishing tasks in a compliant manner with a high degree of integrity following all Regeneron policies
Desired Qualifications
  • Experience in biologics and buy and bill products
  • Demonstrated history of high sales performance
  • Experience with reimbursement programs, government programs, managed care, formulary and contract negotiation
Regeneron Pharmaceuticals

Regeneron Pharmaceuticals

View

Regeneron Pharmaceuticals develops medicines aimed at treating serious diseases such as cancer, eye diseases, and allergic conditions. The company uses its own technologies and extensive research to create new therapies, often collaborating with academic institutions and other pharmaceutical companies to enhance its development efforts. Unlike many competitors, Regeneron focuses on both research and commercialization, generating revenue through the sale of its approved medicines and licensing its technologies. The goal of Regeneron is to improve patient outcomes by providing effective treatments and ensuring that its products meet high safety and efficacy standards.

Company Stage

IPO

Total Funding

$684M

Headquarters

Town of Greenburgh, New York

Founded

1988

Simplify Jobs

Simplify's Take

What believers are saying

  • Regeneron's investment in Truveta enhances its genomic data capabilities for personalized medicine.
  • The Oxular acquisition expands Regeneron's portfolio in retinal disorder treatments.
  • Dupixent's FDA review for CSU could open a new revenue stream for Regeneron.

What critics are saying

  • Class action lawsuits may lead to financial liabilities and reputational damage.
  • Investment in Truveta may not yield expected financial returns.
  • Competition from AstraZeneca and Amgen could impact Regeneron's market share.

What makes Regeneron Pharmaceuticals unique

  • Regeneron leverages proprietary technologies for innovative treatments in serious diseases.
  • The company collaborates with academic and research institutions to enhance R&D efforts.
  • Regeneron's strategic partnerships enable shared costs and profits in new treatment development.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Wellness Program

Paid Vacation

Equity Awards

Annual Bonuses

Flexible Work Hours